Trevi Therapeutics Inc

NASDAQ:TRVI  
2.08
+0.07 (+3.48%)
Other Pre-Announcement

Trevi Therapeutics Announces Fourth Quarter And Year End 2020 Financial Results And Business Updates

Published: 03/25/2021 20:22 GMT
Trevi Therapeutics Inc (TRVI) - Trevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates.
Trevi Therapeutics Inc - Cash Position Expected to Fund Operations Into Q2 of 2022.
Trevi Therapeutics Inc - Expects to Complete Enrollment and Report Top-line Data of Phase 2b/3 Prism Trial in Second Half of 2021.